Published in Nat Struct Mol Biol on March 21, 2010
Activated ClpP kills persisters and eradicates a chronic biofilm infection. Nature (2013) 3.69
ClpXP, an ATP-powered unfolding and protein-degradation machine. Biochim Biophys Acta (2011) 2.17
Substrate delivery by the AAA+ ClpX and ClpC1 unfoldases activates the mycobacterial ClpP1P2 peptidase. Mol Microbiol (2014) 1.62
The Mycobacterium tuberculosis ClpP1P2 Protease Interacts Asymmetrically with Its ATPase Partners ClpX and ClpC1. PLoS One (2015) 1.55
Acyldepsipeptide antibiotics induce the formation of a structured axial channel in ClpP: A model for the ClpX/ClpA-bound state of ClpP. Chem Biol (2010) 1.48
Combination therapies for combating antimicrobial resistance. Curr Opin Microbiol (2011) 1.37
Perrault syndrome is caused by recessive mutations in CLPP, encoding a mitochondrial ATP-dependent chambered protease. Am J Hum Genet (2013) 1.37
The active ClpP protease from M. tuberculosis is a complex composed of a heptameric ClpP1 and a ClpP2 ring. EMBO J (2012) 1.31
Validation of the essential ClpP protease in Mycobacterium tuberculosis as a novel drug target. J Bacteriol (2011) 1.25
Antibiotic acyldepsipeptides activate ClpP peptidase to degrade the cell division protein FtsZ. Proc Natl Acad Sci U S A (2011) 1.22
Bacterial proteolytic complexes as therapeutic targets. Nat Rev Drug Discov (2012) 1.08
Crystal structure of Mycobacterium tuberculosis ClpP1P2 suggests a model for peptidase activation by AAA+ partner binding and substrate delivery. Proc Natl Acad Sci U S A (2014) 1.07
Mechanistic insights into bacterial AAA+ proteases and protein-remodelling machines. Nat Rev Microbiol (2015) 1.01
Restriction of the conformational dynamics of the cyclic acyldepsipeptide antibiotics improves their antibacterial activity. J Am Chem Soc (2014) 0.98
Structural insights into the conformational diversity of ClpP from Bacillus subtilis. Mol Cells (2011) 0.96
Regulated proteolysis in bacterial development. FEMS Microbiol Rev (2013) 0.93
Insights into structural network responsible for oligomerization and activity of bacterial virulence regulator caseinolytic protease P (ClpP) protein. J Biol Chem (2012) 0.92
Structural and functional insights into caseinolytic proteases reveal an unprecedented regulation principle of their catalytic triad. Proc Natl Acad Sci U S A (2013) 0.91
Structural basis of mycobacterial inhibition by cyclomarin A. J Biol Chem (2013) 0.90
Structural switching of Staphylococcus aureus Clp protease: a key to understanding protease dynamics. J Biol Chem (2011) 0.88
Structure and Functional Properties of the Active Form of the Proteolytic Complex, ClpP1P2, from Mycobacterium tuberculosis. J Biol Chem (2016) 0.83
A simple fragment of cyclic acyldepsipeptides is necessary and sufficient for ClpP activation and antibacterial activity. Chembiochem (2014) 0.83
Advances in MRSA drug discovery: where are we and where do we need to be? Expert Opin Drug Discov (2013) 0.82
Acyldepsipeptide antibiotics kill mycobacteria by preventing the physiological functions of the ClpP1P2 protease. Mol Microbiol (2016) 0.81
Escherichia coli ClpB is a non-processive polypeptide translocase. Biochem J (2015) 0.81
Antibiotics: Killing the survivors. Nature (2013) 0.80
CtpB assembles a gated protease tunnel regulating cell-cell signaling during spore formation in Bacillus subtilis. Cell (2013) 0.80
Helix unfolding/refolding characterizes the functional dynamics of Staphylococcus aureus Clp protease. J Biol Chem (2013) 0.77
Examination of a Structural Model of Peptidomimicry by Cyclic Acyldepsipeptide Antibiotics in Their Interaction with the ClpP Peptidase. Chembiochem (2015) 0.76
The N-terminal domain plays a crucial role in the structure of a full-length human mitochondrial Lon protease. Sci Rep (2016) 0.76
Structural and biochemical analyses of the eukaryotic heat shock locus V (HslV) from Trypanosoma brucei. J Biol Chem (2013) 0.76
A Conformationally Constrained Cyclic Acyldepsipeptide Is Highly Effective in Mice Infected with Methicillin-Susceptible and -Resistant Staphylococcus aureus. PLoS One (2016) 0.76
Bacterial proteases, untapped antimicrobial drug targets. J Antibiot (Tokyo) (2016) 0.75
Sclerotiamide: The First Non-Peptide-Based Natural Product Activator of Bacterial Caseinolytic Protease P. J Nat Prod (2016) 0.75
Structure and activation of a heteromeric protease complex. Proc Natl Acad Sci U S A (2014) 0.75
Insights into the molecular evolution of HslU ATPase through biochemical and mutational analyses. PLoS One (2014) 0.75
Insights into ClpXP proteolysis: heterooligomerization and partial deactivation enhance chaperone affinity and substrate turnover in Listeria monocytogenes. Chem Sci (2016) 0.75
Highly Dynamic Interactions Maintain Kinetic Stability of the ClpXP Protease During the ATP-Fueled Mechanical Cycle. ACS Chem Biol (2016) 0.75
Two ways to skin a cat: acyldepsipeptides antibiotics can kill bacteria through activation or inhibition of ClpP activity. Mol Microbiol (2016) 0.75
AAA+ Machines of Protein Destruction in Mycobacteria. Front Mol Biosci (2017) 0.75
Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr (2004) 227.01
Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr (1998) 169.28
Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A (1991) 119.63
Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions. Acta Crystallogr D Biol Crystallogr (2004) 31.52
EMAN: semiautomated software for high-resolution single-particle reconstructions. J Struct Biol (1999) 27.52
Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 A resolution. Science (1995) 12.94
Structure of 20S proteasome from yeast at 2.4 A resolution. Nature (1997) 12.73
An approach to multi-copy search in molecular replacement. Acta Crystallogr D Biol Crystallogr (2000) 7.78
Posttranslational quality control: folding, refolding, and degrading proteins. Science (1999) 5.55
A gated channel into the proteasome core particle. Nat Struct Biol (2000) 5.42
Docking of the proteasomal ATPases' carboxyl termini in the 20S proteasome's alpha ring opens the gate for substrate entry. Mol Cell (2007) 4.54
The structures of HsIU and the ATP-dependent protease HsIU-HsIV. Nature (2000) 4.46
Sculpting the proteome with AAA(+) proteases and disassembly machines. Cell (2004) 3.83
Mechanism of gate opening in the 20S proteasome by the proteasomal ATPases. Mol Cell (2008) 3.49
Proteolysis in bacterial regulatory circuits. Annu Rev Cell Dev Biol (2003) 3.45
Dysregulation of bacterial proteolytic machinery by a new class of antibiotics. Nat Med (2005) 3.40
The proteasome. Annu Rev Biophys Biomol Struct (1999) 3.13
Structural basis for the activation of 20S proteasomes by 11S regulators. Nature (2000) 3.04
The axial channel of the proteasome core particle is gated by the Rpt2 ATPase and controls both substrate entry and product release. Mol Cell (2001) 2.91
ATP-dependent proteases of bacteria: recognition logic and operating principles. Trends Biochem Sci (2006) 2.86
ATP binding to PAN or the 26S ATPases causes association with the 20S proteasome, gate opening, and translocation of unfolded proteins. Mol Cell (2005) 2.82
The 1.9 A structure of a proteasome-11S activator complex and implications for proteasome-PAN/PA700 interactions. Mol Cell (2005) 2.68
Crystal structures of the HslVU peptidase-ATPase complex reveal an ATP-dependent proteolysis mechanism. Structure (2001) 2.63
Crystal and solution structures of an HslUV protease-chaperone complex. Cell (2000) 2.29
Molecular determinants of complex formation between Clp/Hsp100 ATPases and the ClpP peptidase. Nat Struct Biol (2001) 2.18
Distinct static and dynamic interactions control ATPase-peptidase communication in a AAA+ protease. Mol Cell (2007) 1.91
Regulation by proteolysis in bacterial cells. Curr Opin Microbiol (2003) 1.86
Communication between ClpX and ClpP during substrate processing and degradation. Nat Struct Mol Biol (2004) 1.85
ClpP: a distinctive family of cylindrical energy-dependent serine proteases. FEBS Lett (2007) 1.83
Adapting the machine: adaptor proteins for Hsp100/Clp and AAA+ proteases. Nat Rev Microbiol (2009) 1.81
Strategies for macromolecular synchrotron crystallography. Structure (2000) 1.75
Crystal structure of ClpX molecular chaperone from Helicobacter pylori. J Biol Chem (2003) 1.72
Processive degradation of proteins by the ATP-dependent Clp protease from Escherichia coli. Requirement for the multiple array of active sites in ClpP but not ATP hydrolysis. J Biol Chem (1994) 1.72
The antibiotic ADEP reprogrammes ClpP, switching it from a regulated to an uncontrolled protease. EMBO Mol Med (2009) 1.53
The ClpP double ring tetradecameric protease exhibits plastic ring-ring interactions, and the N termini of its subunits form flexible loops that are essential for ClpXP and ClpAP complex formation. J Biol Chem (2005) 1.33
Crystallography and mutagenesis point to an essential role for the N-terminus of human mitochondrial ClpP. J Struct Biol (2004) 1.27
The asymmetry in the mature amino-terminus of ClpP facilitates a local symmetry match in ClpAP and ClpXP complexes. J Struct Biol (2005) 1.27
Crystal structure of HslUV complexed with a vinyl sulfone inhibitor: corroboration of a proposed mechanism of allosteric activation of HslV by HslU. J Mol Biol (2002) 1.21
Crystal structure at 1.9A of E. coli ClpP with a peptide covalently bound at the active site. J Struct Biol (2006) 1.17
Structural basis of SspB-tail recognition by the zinc binding domain of ClpX. J Mol Biol (2007) 1.15
Medicinal chemistry optimization of acyldepsipeptides of the enopeptin class antibiotics. ChemMedChem (2006) 1.02
The structural basis for the activation and peptide recognition of bacterial ClpP. J Mol Biol (2008) 1.01
Crystal structure of the Bowman-Birk inhibitor from barley seeds in ternary complex with porcine trypsin. J Mol Biol (2004) 0.90
Importance of heptameric ring integrity for activity of Escherichia coli ClpP. Eur J Biochem (1998) 0.84
A degradation signal recognition in prokaryotes. J Synchrotron Radiat (2008) 0.79
Dysregulation of bacterial proteolytic machinery by a new class of antibiotics. Nat Med (2005) 3.40
Cutting edge: direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-kappa B. J Immunol (2004) 3.27
Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation. N Engl J Med (2014) 3.12
FAM83H mutations in families with autosomal-dominant hypocalcified amelogenesis imperfecta. Am J Hum Genet (2008) 2.38
Causal relation between spasticity, strength, gross motor function, and functional outcome in children with cerebral palsy: a path analysis. Dev Med Child Neurol (2011) 2.32
SAP couples Fyn to SLAM immune receptors. Nat Cell Biol (2003) 2.27
Cooperation between fixed and low pH-inducible interfaces controls lipoprotein release by the LDL receptor. Mol Cell (2004) 1.89
Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles. J Control Release (2009) 1.81
A single recurrent mutation in the 5'-UTR of IFITM5 causes osteogenesis imperfecta type V. Am J Hum Genet (2012) 1.70
Crystal structure of the FERM domain of focal adhesion kinase. J Biol Chem (2005) 1.57
Structural and functional insights into Dom34, a key component of no-go mRNA decay. Mol Cell (2007) 1.54
The antibiotic ADEP reprogrammes ClpP, switching it from a regulated to an uncontrolled protease. EMBO Mol Med (2009) 1.53
Crystal structure of the periplasmic component of a tripartite macrolide-specific efflux pump. J Mol Biol (2009) 1.50
Origins of peptide selectivity and phosphoinositide binding revealed by structures of disabled-1 PTB domain complexes. Structure (2003) 1.48
Nerve growth factor and prostaglandins in the urine of female patients with overactive bladder. J Urol (2006) 1.44
Development of antisynthetase syndrome in a patient with rheumatoid arthritis. Rheumatol Int (2009) 1.43
Ring-shaped architecture of RecR: implications for its role in homologous recombinational DNA repair. EMBO J (2004) 1.32
Maternal and fetal exposure to bisphenol A in Korea. Reprod Toxicol (2008) 1.31
Mutational spectrum of FAM83H: the C-terminal portion is required for tooth enamel calcification. Hum Mutat (2008) 1.28
Outbreaks of imipenem-resistant Acinetobacter baumannii producing carbapenemases in Korea. J Microbiol (2006) 1.24
Novel FAM20A mutations in hypoplastic amelogenesis imperfecta. Hum Mutat (2011) 1.24
Small cationic antimicrobial peptides delocalize peripheral membrane proteins. Proc Natl Acad Sci U S A (2014) 1.22
Antibiotic acyldepsipeptides activate ClpP peptidase to degrade the cell division protein FtsZ. Proc Natl Acad Sci U S A (2011) 1.22
Discovery of BAY 94-8862: a nonsteroidal antagonist of the mineralocorticoid receptor for the treatment of cardiorenal diseases. ChemMedChem (2012) 1.17
Structure and ubiquitination-dependent activation of TANK-binding kinase 1. Cell Rep (2013) 1.17
MG53-induced IRS-1 ubiquitination negatively regulates skeletal myogenesis and insulin signalling. Nat Commun (2013) 1.16
Changes of urinary nerve growth factor and prostaglandins in male patients with overactive bladder symptom. Int J Urol (2005) 1.15
Structural basis of SspB-tail recognition by the zinc binding domain of ClpX. J Mol Biol (2007) 1.15
Proteomics-based target identification: bengamides as a new class of methionine aminopeptidase inhibitors. J Biol Chem (2003) 1.13
Single cystathionine β-synthase domain-containing proteins modulate development by regulating the thioredoxin system in Arabidopsis. Plant Cell (2011) 1.12
Functional interactions of HslV (ClpQ) with the ATPase HslU (ClpY). Proc Natl Acad Sci U S A (2002) 1.08
Muscarinic and purinergic receptor expression in the urothelium of rats with detrusor overactivity induced by bladder outlet obstruction. BJU Int (2007) 1.07
Structural basis for the recognition of N-end rule substrates by the UBR box of ubiquitin ligases. Nat Struct Mol Biol (2010) 1.07
Insights into noncanonical E1 enzyme activation from the structure of autophagic E1 Atg7 with Atg8. Nat Struct Mol Biol (2011) 1.06
Tumor-homing poly-siRNA/glycol chitosan self-cross-linked nanoparticles for systemic siRNA delivery in cancer treatment. Angew Chem Int Ed Engl (2012) 1.04
Docetaxel plus cisplatin as second-line therapy in metastatic or recurrent advanced gastric cancer progressing on 5-fluorouracil-based regimen. Am J Clin Oncol (2004) 1.04
Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly(beta-amino ester) block copolymer micelles for cancer therapy. J Control Release (2007) 1.03
A dentin sialophosphoprotein mutation that partially disrupts a splice acceptor site causes type II dentin dysplasia. J Endod (2008) 1.03
Effect of Prolyl-hydroxyproline (Pro-Hyp), a food-derived collagen peptide in human blood, on growth of fibroblasts from mouse skin. J Agric Food Chem (2009) 1.03
Inducing secondary metabolite production by the endophytic fungus Fusarium tricinctum through coculture with Bacillus subtilis. J Nat Prod (2013) 1.02
Medicinal chemistry optimization of acyldepsipeptides of the enopeptin class antibiotics. ChemMedChem (2006) 1.02
Gefitinib (ZD1839) monotherapy as a salvage regimen for previously treated advanced non-small cell lung cancer. Clin Cancer Res (2004) 1.01
New class of bacterial phenylalanyl-tRNA synthetase inhibitors with high potency and broad-spectrum activity. Antimicrob Agents Chemother (2004) 0.99
Low-carbohydrate diet versus caloric restriction: effects on weight loss, hormones, and colon tumor growth in obese mice. Nutr Cancer (2008) 0.99
Histologic confirmation of huge pancreatic lipoma: a case report and review of literatures. J Korean Surg Soc (2011) 0.99
Phospholipase Cgamma activation drives increased production of autotaxin in endothelial cells and lysophosphatidic acid-dependent regression. Mol Cell Biol (2010) 0.96
Structural insights into the conformational diversity of ClpP from Bacillus subtilis. Mol Cells (2011) 0.96
Crystal structure of PRY-SPRY domain of human TRIM72. Proteins (2010) 0.96
Crystal structure of a coiled-coil domain from human ROCK I. PLoS One (2011) 0.95
Complex of Fas-associated factor 1 (FAF1) with valosin-containing protein (VCP)-Npl4-Ufd1 and polyubiquitinated proteins promotes endoplasmic reticulum-associated degradation (ERAD). J Biol Chem (2013) 0.94
Chimeric capsid protein as a nanocarrier for siRNA delivery: stability and cellular uptake of encapsulated siRNA. ACS Nano (2011) 0.94
Knockdown of β-catenin controls both apoptotic and autophagic cell death through LKB1/AMPK signaling in head and neck squamous cell carcinoma cell lines. Cell Signal (2012) 0.94
Expression of toll-like receptor 4 contributes to corneal inflammation in experimental dry eye disease. Invest Ophthalmol Vis Sci (2012) 0.94
STAM-AMSH interaction facilitates the deubiquitination activity in the C-terminal AMSH. Biochem Biophys Res Commun (2006) 0.94
Crystal structure of ubiquitin-like small archaeal modifier protein 1 (SAMP1) from Haloferax volcanii. Biochem Biophys Res Commun (2011) 0.94
Coupling of ryanodine receptor 2 and voltage-dependent anion channel 2 is essential for Ca²+ transfer from the sarcoplasmic reticulum to the mitochondria in the heart. Biochem J (2012) 0.94
Facile synthesis of monodispersed mesoporous silica nanoparticles with ultralarge pores and their application in gene delivery. ACS Nano (2011) 0.93
Bacterial cell division as a target for new antibiotics. Curr Opin Microbiol (2013) 0.93
Interleukin-6 treatment induces beta-cell apoptosis via STAT-3-mediated nitric oxide production. Diabetes Metab Res Rev (2011) 0.93
Identification, structural, and biochemical characterization of a group of large Csn2 proteins involved in CRISPR-mediated bacterial immunity. Proteins (2012) 0.93
Crystal structure of Helicobacter pylori MinE, a cell division topological specificity factor. Mol Microbiol (2010) 0.93
Alpha-synuclein is localized in a subpopulation of rat brain synaptic vesicles. Acta Neurobiol Exp (Wars) (2008) 0.92
Swiprosin-1 is a novel actin bundling protein that regulates cell spreading and migration. PLoS One (2013) 0.92
Preemptive treatment of Cytomegalovirus infection in kidney transplant recipients with letermovir: results of a Phase 2a study. Transpl Int (2014) 0.92
Expression, purification and biochemical characterization of the N-terminal regions of human TIG3 and HRASLS3 proteins. Protein Expr Purif (2010) 0.92
Methylmercury exposure and health effects. J Prev Med Public Health (2012) 0.92
Effect of mosapride combined with esomeprazole improves esophageal peristaltic function in patients with gastroesophageal reflux disease: a study using high resolution manometry. Dig Dis Sci (2012) 0.91
Cost and effectiveness of the nationwide government-supported Smoking Cessation Clinics in the Republic of Korea. Tob Control (2012) 0.91
The gene expression profiling in murine cortical cells undergoing programmed cell death (PCD) induced by serum deprivation. J Biochem Mol Biol (2007) 0.91
The effects of single-dose intravenous dexmedetomidine on hyperbaric bupivacaine spinal anesthesia. J Anesth (2013) 0.91
Expression patterns of the Fam83h gene during murine tooth development. Arch Oral Biol (2009) 0.90
Effects of Fam83h overexpression on enamel and dentine formation. Arch Oral Biol (2013) 0.90
Ubiquitin ligases of the N-end rule pathway: assessment of mutations in UBR1 that cause the Johanson-Blizzard syndrome. PLoS One (2011) 0.90
Crystal structure of the Bowman-Birk inhibitor from barley seeds in ternary complex with porcine trypsin. J Mol Biol (2004) 0.90
Efficient regioselective synthesis of 6-amino-5-benzoyl-1-substituted 2(1H)-pyridinones. J Org Chem (2005) 0.89
A role for a menthone reductase in resistance against microbial pathogens in plants. Plant Physiol (2008) 0.89
Homotetrameric structure of the SNAP-23 N-terminal coiled-coil domain. J Biol Chem (2003) 0.89
Magnetite-nanoparticle-encapsulated pH-responsive polymeric micelle as an MRI probe for detecting acidic pathologic areas. Small (2010) 0.89
Role of Junctin protein interactions in cellular dynamics of calsequestrin polymer upon calcium perturbation. J Biol Chem (2011) 0.88
Cost-effectiveness analysis of HLA-B5801 genotyping in the treatment of gout patients with chronic renal insufficiency in Korea. Arthritis Care Res (Hoboken) (2015) 0.88
Protein-phosphorylation-responsive polymeric nanoparticles for imaging protein kinase activities in single living cells. Angew Chem Int Ed Engl (2007) 0.88
Structural basis for recognition of autophagic receptor NDP52 by the sugar receptor galectin-8. Nat Commun (2013) 0.88
Rapid degradation of replication-dependent histone mRNAs largely occurs on mRNAs bound by nuclear cap-binding proteins 80 and 20. Nucleic Acids Res (2012) 0.88
The impact of transcriptome and proteome analyses on antibiotic drug discovery. Curr Opin Microbiol (2004) 0.88
Assembly of multimeric phage nanostructures through leucine zipper interactions. Biotechnol Bioeng (2006) 0.87
Crystal structure of human nucleoside diphosphate kinase A, a metastasis suppressor. Proteins (2002) 0.87
Depletion of nucleophosmin via transglutaminase 2 cross-linking increases drug resistance in cancer cells. Cancer Lett (2008) 0.87
Radioresistant cancer cells can be conditioned to enter senescence by mTOR inhibition. Cancer Res (2013) 0.87
Efficient functional delivery of siRNA using mesoporous silica nanoparticles with ultralarge pores. Small (2012) 0.87
Ischemic preconditioning-induced neuroprotection is associated with differential expression of IL-1beta and IL-1 receptor antagonist in the ischemic cortex. J Neuroimmunol (2009) 0.86